Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase

Siaw Eng Ho1, Geetha Subramaniam, Selvi Palasubramaniam

  • 1Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.

Insights

A carbapenem-resistant Pseudomonas aeruginosa strain producing IMP-7 metallo-beta-lactamase was identified in Malaysia. This discovery highlights the spread of antimicrobial resistance and the need for effective treatment strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen.
  • Carbapenem resistance is a growing global health concern.
  • Metallo-beta-lactamases (MBLs) are key enzymes conferring carbapenem resistance.

Purpose of the Study:

  • To isolate and identify carbapenem-resistant Pseudomonas aeruginosa from Malaysia.
  • To characterize the resistance mechanisms, specifically metallo-beta-lactamase production.

Main Methods:

  • Isolation and identification of bacterial strains.
  • Antimicrobial susceptibility testing (MIC determination).
  • Isoelectric focusing (IEF) for enzyme characterization.
  • DNA sequencing for determinant identification.

Main Results:

  • A carbapenem-resistant Pseudomonas aeruginosa strain was isolated from Malaysia.
  • The isolate exhibited high-level resistance to meropenem (MIC: 256 µg/ml) and imipenem (MIC: 128 µg/ml).
  • IMP-7 metallo-beta-lactamase was identified as the resistance determinant.

Conclusions:

  • The presence of IMP-7 in Malaysia signifies a new geographical spread of this carbapenemase.
  • This finding underscores the urgent need for enhanced surveillance and infection control measures.
  • Understanding resistance mechanisms is crucial for developing effective therapeutic interventions.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...